Changes of the Plasma Atrial Natriuretic Peptide during Myocardial Infarction in Rats

흰쥐 심근경색 모델에서 혈장 Atrial Natriuretic Peptide의 변화

  • Ahn, Dong-Choon (Department of Veterinary Anatomy, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) ;
  • Kim, In-Shik (Department of Veterinary Anatomy, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University)
  • 안동춘 (전북대학교 생체안전성연구소, 수의과대학 해부학교실) ;
  • 김인식 (전북대학교 생체안전성연구소, 수의과대학 해부학교실)
  • Accepted : 2012.02.09
  • Published : 2012.04.30

Abstract

Atrial natriuretic peptide (ANP) is associated with the variety of disorders of myocardial function. The effect, however, of myocardial infarction (MI) on ANP has not been fully described. Thus, this study investigated the effect of experimental MI, induced by left coronary artery ligation, on ANP secretion. Male Sprague-Dawley rats aged 60 d underwent ligation of the left anterior descending coronary artery to induce MI and were compared with a group that underwent a sham operation. Rats of sham operation had a similar procedure without having the suture tightened around the coronary artery. Animals were sacrificed at 1, 3, 6, 12, and 18 h or 1, 3, 5, 7, 14, and 30 d after the procedure. MI size was assessed by planimetry and perimetry, and plasma ANP levels were determined by radioimmunoassay. Mean infarct size was 39.6-44.5% of the left ventricle after coronary occlusion in experimental groups. No significant differences were observed in infarct size among groups. In contrast, the concentration of plasma ANP was significantly higher at 1, 3, 6, 12, 18, and 24 h after left coronary artery ligation than in sham animals. This parameter, however, did not differ significantly at 3, 5, 7, 14, and 30 d after ligation compared with sham-ligated controls. These results demonstrate that plasma ANP levels are markedly increased in the early phase of MI in the male rat and can be a useful biomarker for diagnosis in acute MI.

Atrial natriuretic peptide (ANP)은 여러 가지 다양한 심근질환과 연관성이 있는 것으로 알려져 있으나 심근경색에서 ANP의 변화에 대해서는 명확하게 밝혀져 있지 않다. 따라서 본 연구에서는 흰쥐 심근경색 모델을 활용하여 혈장내 ANP의 변화를 살펴보아 심근경색에서 ANP의 역할을 규명해보고자 하였다. 수컷 흰쥐 60일령에서 왼심장동맥을 결찰 하여 심근경색 모델을 만들었고 개흉하여 sham 대조군을 삼았다. 각각의 실험군과 대조군을 수술 후 1, 3, 6, 12, 18시간과 1, 3, 5, 7, 14 및 30일에 희생시켜 실험에 사용하였다. 심근경색의 크기는 planimetry와 perimetry법을 적용하여 측정하였고 혈장내 ANP 농도는 방사면역측정법을 적용하여 측정하였다. 왼심장동맥을 결찰한 실험군에서 평균 심근경색의 크기는 왼심실의 39.6-44.5%이었고 유의성 있는 차이는 없었다. 혈장내 ANP 농도는 심근경색 후 1, 3, 6, 12, 18 및 24시간에 대조군에 비하여 명확하게 증가하였으나 3, 5, 7, 14 및 30일령에서 ANP 농도는 대조군에 비하여 유의성 있는 차이를 나타내지 않았다. 이러한 결과는 수컷 흰쥐에서 혈장내 ANP 농도는 심근경색 초기에 명확하게 증가함을 입증하였고 급성심근경색의 진단을 위한 생체표지인자로 이용할 수 있는 가능성을 제시해주고 있다.

Keywords

References

  1. Ahn DC, Cheng L, Moon C, Spurgeon H, Lakatta EG, Talan MI. Induction of myocardial infarcts of a predicable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. Am J Physiol 2004; 286: 1201-1207.
  2. Ahn DC, Kim IS. An anatomical study on the branching patterns of left coronary artery in the rat. Korean J Vet Res 2007; 47: 7-17.
  3. Burnett JC, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145-1147. https://doi.org/10.1126/science.2935937
  4. Cantin M, Genest J. The heart and the atrial natriuretic factor. J Endocr Rev 1985; 6: 107-127. https://doi.org/10.1210/edrv-6-2-107
  5. Chimoskey JE, Spielman WS, Brandt MA, Heidemann SR. Cardiac atria of BIO 14.6 hamsters are deficient in natriuretic factor. Science 1984; 223: 820-822. https://doi.org/10.1126/science.6538050
  6. Cho KW, Kim SH, Kim CH, Koh GY. Mechanical basis of ANP secretion in beating atria: Atrial stroke volume and ECF translocation. Am J Physiol 1995; 268: 1129-1136.
  7. Cho KW, Seul KH, Kim SH, Seul KM, Koh GY. Atrial pressure, distension, and pacing frequency in ANP secretion in isolated perfused rabbit atria. Am J Physiol 1991; 260: 39-46.
  8. Cho KW, Seul KH, Kim SH, Seul KM, Ryu H, Koh GY. Reduction volume dependence of immunoreactive atrial natriuretic peptide secretion in isolated perfused rabbit atria. J Hypertens 1989; 7: 371-375. https://doi.org/10.1097/00004872-198905000-00004
  9. de Bold AJ. Heart atrial granularity : effects of changes in water-electrolyte balance. Exp Biol Med 1979; 161: 508-511. https://doi.org/10.3181/00379727-161-40584
  10. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191-195. https://doi.org/10.1161/01.RES.62.2.191
  11. Haggstrom J, Hansson K, Karlberg BE, Kvart C, Olsson K. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994; 55: 698-703.
  12. Hostetter TH, Pfeffer JM, Pfeffer MA, Dworkin LD, Braunwald E, Brenner BM. Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol 1983; 245: 98-103.
  13. Kinugawa T, Endo A, Kato M. Responses of plasma catecholamines, renin-angiotensin-aldosterone system and atrial natriuretic peptide to exercise in patients with essential hypertension. Cardiology 1997; 88: 238-245. https://doi.org/10.1159/000177336
  14. Kohzuki M, Hodsman GP, Johnston CI. Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Am J Physiol 1989; 256: 533-538.
  15. Lee RW, Gay RG, Moffett C, Johnson DG, Goldman S. Atrial natriuretic peptide levels during development of chronic heart failure after myocardial infarction in rats. Life Sci 1987; 40: 2025-2030. https://doi.org/10.1016/0024-3205(87)90294-3
  16. Mendez RE, Pfeffer JM, Ortola FV, Bloch KD, Anderson S, Seidman JG, Brenner BM. Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am J Physiol 1987; 253: 1449-1455.
  17. Metzler CH, Gardner DG, Keil LC, Baxter JD, Ramsay DJ. Increased synthesis and release of atrial peptide during DOCA escape in conscious dogs. Am J Physiol 1987; 252: 188-192.
  18. Morii N, Nakao K, Kihara M, Sugawara A, Sakamoto M, Yamori Y, Imura H. Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR strokeprone. Biochem Biophys Res Commun 1986; 135: 74-81. https://doi.org/10.1016/0006-291X(86)90944-7
  19. Needleman P, Greenwald JE. Atriopeptin : a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med 1986; 314: 828-834. https://doi.org/10.1056/NEJM198603273141306
  20. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503-512. https://doi.org/10.1161/01.RES.44.4.503
  21. Rector TS, Carlyle PF, Cohn JN. Reduced atrial natriuretic factor after ligation of the left coronary artery in rats. Am Heart J 1985; 110: 1197-1199. https://doi.org/10.1016/0002-8703(85)90012-2
  22. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992; 44: 479-602.
  23. Shenker Y, Sider RS, Ostafin EA, Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684-1687. https://doi.org/10.1172/JCI112154
  24. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1998; 332: 131-139.
  25. Sudoh T, Minamino N, Kangwa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide member family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863-870. https://doi.org/10.1016/0006-291X(90)92401-K
  26. Tae HJ, Ahn DC, Park BY, Kim IS. Regulation of IGF system in rats after experimental myocardial infarction. Korean J Phys Anthropol 2011; 24: 67-76. https://doi.org/10.11637/kjpa.2011.24.2.67
  27. Takemura N, Koyama H, Sako T, Ando K, Motoyoshi S, Marumo F. Plasma atrial natriuretic peptide (ANP) in dogs with mild heartworm infection. J Vet Med Sci 1991; 53: 323-325. https://doi.org/10.1292/jvms.53.323
  28. Tikkanen I, Fyhrquist R, Metsarinne K, Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet 1985; 2: 66-69.
  29. Tikkanen T, Tikkanen I, Fyhrquist F. Elevated plasma atrial natriuretic peptide in rats with myocardial infarcts. Life Sci 1987; 40: 659-663. https://doi.org/10.1016/0024-3205(87)90267-0
  30. Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res 1986; 59: 256-261. https://doi.org/10.1161/01.RES.59.3.256
  31. Vollmar AM, Montag C, Preusser U, Kraft W, Schulz R. Atrial natriuretic peptide and plasma volume of dogs suffering from heart failure or dehydration. J Vet Med A 1994; 41: 548-557.
  32. Wijeyaratne CN, Moult PJA. The effect of a human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. J Clin Endocrinol Metab 1993; 76: 343-346. https://doi.org/10.1210/jc.76.2.343